BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33401302)

  • 21. Impact of hand and face disabilities on global disability and quality of life in systemic sclerosis patients.
    Maddali-Bongi S; Del Rosso A; Mikhaylova S; Francini B; Branchi A; Baccini M; Matucci-Cerinic M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-15-20. PubMed ID: 24850211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evaluation of a home-based program for hands in patients with systemic sclerosis.
    Landim SF; Bertolo MB; Marcatto de Abreu MF; Del Rio AP; Mazon CC; Marques-Neto JF; Poole JL; de Paiva Magalhães E
    J Hand Ther; 2019; 32(3):313-321. PubMed ID: 29198478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis.
    Nagy G; Dobrota R; Becker MO; Minier T; Varjú C; Kumánovics G; Distler O; Czirják L
    Arthritis Res Ther; 2023 May; 25(1):84. PubMed ID: 37210571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hand functions in systemic sclerosis and rheumatoid arthritis and influence on clinical variables.
    Erol K; Gok K; Cengiz G; Ozgocmen S
    Int J Rheum Dis; 2018 Jan; 21(1):249-252. PubMed ID: 28322506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluations and analyses of quality of life in 90 patients with systemic sclerosis by health assessment questionnaire-disability index].
    Mao X; Sun Q
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(44):3471-4. PubMed ID: 25622735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Pain Characteristics in Patients with Rheumatoid Arthritis and Systemic Sclerosis with Particular Reference to the Neuropathic Pain Component: Cross-Sectional Study.
    Cengiz G; Erol K; Gok K; Ozgocmen S
    Med Princ Pract; 2018; 27(6):537-542. PubMed ID: 30184532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional Disability among Systemic Sclerosis Patients: Relation to Disease Characteristics and Quality of Life Parameters.
    Zaghlol RS; Dawa GA; Makarm WK
    Curr Rheumatol Rev; 2022; 18(3):257-265. PubMed ID: 34847844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclinical coronary atherosclerosis, detected by computer tomography with coronary calcium score, and the occurrence of major cardiovascular events at 5 years of follow-up in a cohort of patients with systemic sclerosis.
    Rotondo C; Sciacca S; Rella V; Busto G; Colia R; Cantatore FP; Corrado A
    Eur J Intern Med; 2023 Sep; 115():62-69. PubMed ID: 37316356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and Morbidity.
    Schwender E; Hansen D; Stevens W; Ross L; Proudman S; Walker J; Sahhar J; Ngian G; Host L; Major G; Nikpour M; Morrisroe K
    Arthritis Care Res (Hoboken); 2024 Jun; 76(6):760-767. PubMed ID: 38327022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of psychological functioning upon systemic sclerosis patients' quality of life.
    Hyphantis TN; Tsifetaki N; Siafaka V; Voulgari PV; Pappa C; Bai M; Palieraki K; Venetsanopoulou A; Mavreas V; Drosos AA
    Semin Arthritis Rheum; 2007 Oct; 37(2):81-92. PubMed ID: 17512572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Preventive Role of Physical Activity in Systemic Sclerosis: A Cross-Sectional Study on the Correlation with Clinical Parameters and Disease Progression.
    Antinozzi C; Grazioli E; De Santis M; Motta F; Sgrò P; Mari F; Mauri C; Parisi A; Caporossi D; Duranti G; Ceci R; Di Luigi L; Dimauro I
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma.
    Müller H; Rehberger P; Günther C; Schmitt J
    Br J Dermatol; 2012 Feb; 166(2):343-53. PubMed ID: 21916888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical and economic burden of systemic sclerosis related interstitial lung disease.
    Morrisroe K; Stevens W; Sahhar J; Ngian GS; Ferdowsi N; Hansen D; Patel S; Hill CL; Roddy J; Walker J; Proudman S; Nikpour M
    Rheumatology (Oxford); 2020 Aug; 59(8):1878-1888. PubMed ID: 31740961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey.
    Frantz C; Avouac J; Distler O; Amrouche F; Godard D; Kennedy AT; Connolly K; Varga J; Matucci-Cerinic M; Allanore Y
    Semin Arthritis Rheum; 2016 Aug; 46(1):115-23. PubMed ID: 27132536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients.
    Mugii N; Someya F; Noto S; Hamaguchi Y; Matsushita T; Takehara K
    Mod Rheumatol; 2020 Jul; 30(4):681-686. PubMed ID: 31269847
    [No Abstract]   [Full Text] [Related]  

  • 40. The economic burden and health-related quality of life associated with systemic sclerosis in France.
    Chevreul K; Brigham KB; Gandré C; Mouthon L;
    Scand J Rheumatol; 2015 May; 44(3):238-46. PubMed ID: 25521915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.